INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 299 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,366,859 | +20.0% | 232,981 | +54.8% | 0.00% | +33.3% |
| Q2 2023 | $6,136,656 | +54784.7% | 150,482 | -49.8% | 0.00% | -50.0% |
| Q1 2023 | $11,181 | +184.0% | 299,990 | +165.9% | 0.01% | +200.0% |
| Q4 2022 | $3,937 | -100.0% | 112,821 | -65.9% | 0.00% | -81.8% |
| Q3 2022 | $18,492,000 | -28.6% | 330,442 | -34.0% | 0.01% | -31.2% |
| Q2 2022 | $25,900,000 | -35.2% | 500,389 | -9.1% | 0.02% | -23.8% |
| Q1 2022 | $39,988,000 | +2065.0% | 550,266 | +3422.6% | 0.02% | +2000.0% |
| Q4 2021 | $1,847,000 | -86.5% | 15,621 | -84.7% | 0.00% | -87.5% |
| Q3 2021 | $13,719,000 | -75.5% | 102,267 | -70.4% | 0.01% | -76.5% |
| Q2 2021 | $56,029,000 | +33.4% | 346,050 | -33.9% | 0.03% | +13.3% |
| Q1 2021 | $42,007,000 | +124.7% | 523,426 | +52.3% | 0.03% | +130.8% |
| Q4 2020 | $18,694,000 | +102.3% | 343,639 | -26.1% | 0.01% | +18.2% |
| Q3 2020 | $9,243,000 | +222.3% | 464,919 | +240.8% | 0.01% | +175.0% |
| Q2 2020 | $2,868,000 | +1056.5% | 136,425 | +708.4% | 0.00% | – |
| Q4 2019 | $248,000 | -6.1% | 16,875 | -14.9% | 0.00% | – |
| Q3 2019 | $264,000 | -93.1% | 19,827 | -91.6% | 0.00% | -100.0% |
| Q2 2019 | $3,847,000 | +310.1% | 235,017 | +327.9% | 0.01% | +500.0% |
| Q1 2019 | $938,000 | +22.0% | 54,918 | -2.5% | 0.00% | 0.0% |
| Q4 2018 | $769,000 | +12.6% | 56,355 | +58.6% | 0.00% | 0.0% |
| Q4 2017 | $683,000 | +48.8% | 35,543 | +24.0% | 0.00% | 0.0% |
| Q2 2017 | $459,000 | +25.8% | 28,672 | +10.8% | 0.00% | 0.0% |
| Q1 2017 | $365,000 | -82.4% | 25,881 | -83.7% | 0.00% | -75.0% |
| Q4 2016 | $2,079,000 | -9.0% | 158,551 | +18.1% | 0.00% | 0.0% |
| Q3 2016 | $2,285,000 | – | 134,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |